Kindeva has promoted David Stevens, Chief Operating and Commercial Officer, to the newly created role of President.

The FDA approved of Blenrep in combination with bortezomib and dexamethasone (BVd) for adults with relapsed or refractory multiple myeloma who have received at least two prior therapies.

Disaster recovery is more than contingency planning. Philip Bradley of Astoriom explains why it must be embedded in pharma’s sample storage strategies.

Schwab-Hautzinger rejoins Roche from her role at BASF as Head of Corporate Communications and Government Relations.

Aenova is investing in its sterile manufacturing capabilities with the installation of another fill & finish (F&F) line at its Latina, Italy site.

Secarna Pharmaceuticals has signed an agreement with Scenic Biotech covering the discovery and co-development of oligonucleotides against a novel target.

BioMed X has introduced a new research team at its Heidelberg institute for multispecific biologics in the field of immuno-oncology in collaboration with Daiichi Sankyo.

Alloy Therapeutics has acquired Spannerwerks LLC, a consultancy that advises biopharmaceutical companies on product development and commercialization.

New campus will encompass a 50,000 ft2 manufacturing facility, with an adjacent 50,000 ft2 space for specialized packaging and supply chain operations.